Are you Dr. Yel?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 13 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Uci Medical Center
101 The City Drive South
Orange, CA 92868Phone+1 714-456-2986- Is this information wrong?
Summary
- Dr. Leman Yel, MD is an allergist/immunologist in Orange, California. She is currently licensed to practice medicine in California.
Education & Training
- University of TennesseeResidency, Pediatrics, 1997 - 2000
- Hacettepe University FOMClass of 1985
Certifications & Licensure
- CA State Medical License 1998 - 2026
Awards, Honors, & Recognition
- Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Ceprotin Treatment Registry Start of enrollment: 2010 Jun 23
- Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric PIDD Subjects Start of enrollment: 2017 May 30
- Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects Start of enrollment: 2017 Sep 25
Publications & Presentations
PubMed
- Population pharmacokinetics of immunoglobulin G after intravenous, subcutaneous, or hyaluronidase-facilitated subcutaneous administration in immunoglobulin-naive patie...Li, Z., Follman, K., Freshwater, E., Engler, F., Yel, L.> ;International Immunopharmacology. 2024 Feb 15
- Pharmacokinetics, safety, and efficacy of 20% subcutaneous immunoglobulin (Ig20Gly) administered weekly or every 2 weeks in Japanese patients with primary immunodefici...Hirokazu Kanegane, Akifumi Endo, Satoshi Okada, Hidenori Ohnishi, Masataka Ishimura, Ryuta Nishikomori, Kohsuke Imai, Shigeaki Nonoyama, Hideki Muramatsu, Taizo Wada, ...> ;Immunotherapy Advances. 2024 Jan 1
- A Phase 1 Open-Label Study to Assess the Tolerability, Safety, and Immunogenicity of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 20% in Healthy Adults.Nagy, A., Duff, K., Bauer, A., Okonneh, F., Rondon, J., Li, Z., Yel, L.> ;Journal of Clinical Immunology. 2023 Dec 22
- Join now to see all
Professional Memberships
- Fellow
- Fellow